1. Home
  2. NBHC vs GENB Comparison

NBHC vs GENB Comparison

Compare NBHC & GENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo National Bank Holdings Corporation

NBHC

National Bank Holdings Corporation

HOLD

Current Price

$41.40

Market Cap

1.9B

Sector

Finance

ML Signal

HOLD

GENB

Generate Biomedicines Inc. Common Stock

N/A

Current Price

$15.71

Market Cap

1.9B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
NBHC
GENB
Founded
2009
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.9B
IPO Year
2011
2026

Fundamental Metrics

Financial Performance
Metric
NBHC
GENB
Price
$41.40
$15.71
Analyst Decision
Buy
Strong Buy
Analyst Count
3
6
Target Price
$47.67
$23.20
AVG Volume (30 Days)
295.2K
1.4M
Earning Date
04-21-2026
05-11-2026
Dividend Yield
3.03%
N/A
EPS Growth
N/A
N/A
EPS
1.04
N/A
Revenue
$47,100,000.00
N/A
Revenue This Year
$39.96
N/A
Revenue Next Year
$7.14
$16.58
P/E Ratio
$39.73
N/A
Revenue Growth
2.86
N/A
52 Week Low
$35.06
$11.00
52 Week High
$47.28
$22.67

Technical Indicators

Market Signals
Indicator
NBHC
GENB
Relative Strength Index (RSI) 41.22 49.97
Support Level $40.47 $12.05
Resistance Level $42.74 $17.46
Average True Range (ATR) 0.61 1.63
MACD 0.06 -0.14
Stochastic Oscillator 51.63 12.32

Price Performance

Historical Comparison
NBHC
GENB

About NBHC National Bank Holdings Corporation

National Bank Holdings Corp offers a full range of banking products and financial services to commercial, business, and consumer clients predominantly in Colorado, with a focus on personalized service through relationship managers and banking center associates. The company provides commercial and industrial loans, non-owner occupied commercial real estate loans, Small Business Administration loans as a Preferred Lender Provider, U.S. Department of Agriculture and Farm Service Agency loans, commercial deposit and treasury management products, business online and mobile banking, consumer and residential real estate loans, deposit services, and trust and wealth management services. Its services emphasize full-relationship banking, integrating lending, deposits, and cash management solutions.

About GENB Generate Biomedicines Inc. Common Stock

Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.

Share on Social Networks: